Cancer NetworkOriginal article
<![CDATA[CAR T-Cell Expansion Predicts Toxicity, But Not Always Efficacy]]>
Data Readoutcilta-celide-celNeutral
AI Analysis
Summary
Expert commentary on CAR T-cell expansion biomarker shows differential toxicity prediction between cilta-cel and ide-cel therapies. The analysis suggests expansion patterns may not universally predict both safety and efficacy outcomes across different CAR T products.
Outcome Details
CAR T-cell expansion signals toxicity risk differently across cilta-cel and ide-cel
Importance:3/10
Sentiment:
0.00
CAR-T cell therapytoxicitycilta-celide-celcell expansion
Read the original article
Published by Cancer Network on July 26, 2026 4:00 PM